Free Trial
→ Alert: DOGE goes live (From Altimetry) (Ad) Buy DXCM Stock  Free DXCM Stock Alerts

DexCom (DXCM) Short Interest Ratio & Short Volume

DexCom logo
$73.05 -2.27 (-3.01%)
As of 03:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

DexCom Short Interest Data

DexCom (DXCM) has a short interest of 9.87 million shares, representing 2.53% of the float (the number of shares available for trading by the public). This marks a 4.11% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.7, indicating that it would take 2.7 days of the average trading volume of 3.92 million shares to cover all short positions.

Current Short Interest
9,870,000 shares
Previous Short Interest
9,480,000 shares
Change Vs. Previous Month
+4.11%
Dollar Volume Sold Short
$872.21 million
Short Interest Ratio
2.7 Days to Cover
Last Record Date
February 28, 2025
Outstanding Shares
390,772,000 shares
Short Percent of Float
2.53%
Today's Trading Volume
1,759,777 shares
Average Trading Volume
3,915,036 shares
Today's Volume Vs. Average
45%
Short Selling DexCom?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for DexCom and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

DXCM Short Interest Over Time

DXCM Days to Cover Over Time

DXCM Percentage of Float Shorted Over Time

Remove Ads

DexCom Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/20259,870,000 shares $872.21 million +4.1%2.5%2.7 $88.37
2/15/20259,480,000 shares $844.38 million -3.8%2.4%2.7 $89.07
1/31/20259,850,000 shares $855.28 million +11.8%N/A2.8 $86.83
1/15/20258,810,000 shares $708.32 million +0.1%N/A2.2 $80.40
12/31/20248,800,000 shares $684.38 million -5.7%N/A2.3 $77.77
12/15/20249,330,000 shares $720.18 million +10.8%N/A2.3 $77.19
11/30/20248,420,000 shares $656.68 million -7.7%N/A2 $77.99
11/15/20249,120,000 shares $692.03 million -2.6%N/A2.1 $75.88
10/31/20249,360,000 shares $659.69 million +21.9%N/A2.2 $70.48
10/15/20247,680,000 shares $515.33 million -19.6%N/A1.3 $67.10
9/30/20249,550,000 shares $640.23 million +11.7%N/A1.7 $67.04
9/15/20248,550,000 shares $594.31 million +16.6%N/A1.6 $69.51
8/31/20247,330,000 shares $508.26 million -3.0%N/A1.4 $69.34
8/15/20247,560,000 shares $547.04 million +7.2%N/A1.5 $72.36
7/31/20247,050,000 shares $478.13 million -32.3%N/A1.5 $67.82
7/15/202410,420,000 shares $1.18 billion +1.1%N/A3.8 $113.01
6/30/202410,310,000 shares $1.17 billion +14.4%N/A3.8 $113.38
6/15/20249,010,000 shares $1.04 billion +3.1%N/A3.2 $115.95
5/31/20248,740,000 shares $1.04 billion +12.3%N/A3.2 $118.77
5/15/20247,780,000 shares $1.01 billion -29.9%N/A2.7 $129.71
4/30/202411,100,000 shares $1.41 billion -5.7%N/A3.6 $127.39
4/15/202411,770,000 shares $1.58 billion -19.2%N/A3.9 $134.56
3/31/202414,570,000 shares $2.02 billion -8.2%N/A4.7 $138.70
3/15/202415,870,000 shares $2.07 billion -4.7%N/A5.3 $130.46
2/29/202416,650,000 shares $1.92 billion -2.5%N/A5.4 $115.07
2/15/202417,070,000 shares $2.01 billion -8.0%N/A5.7 $117.69
1/31/202418,560,000 shares $2.25 billion +1.8%N/A5.9 $121.35
1/15/202418,240,000 shares $2.28 billion -0.9%N/A5 $125.00
12/31/202318,410,000 shares $2.28 billion -2.9%N/A4.4 $124.09
12/15/202318,960,000 shares $2.32 billion -0.8%N/A4.1 $122.59
11/30/202319,120,000 shares $2.21 billion +7.7%N/A3.9 $115.52
11/15/202317,750,000 shares $1.81 billion -15.7%N/A3.4 $102.11
10/31/202321,060,000 shares $1.87 billion +30.7%N/A4.2 $88.83
10/15/202316,110,000 shares $1.23 billion +2.0%N/A3.5 $76.19
9/30/202315,800,000 shares $1.47 billion -1.4%N/A3.8 $93.30
9/15/202316,030,000 shares $1.54 billion -5.3%N/A4.4 $96.35
8/31/202316,920,000 shares $1.71 billion +0.8%N/A5 $100.98
8/15/202316,780,000 shares $1.92 billion +11.9%N/A5.4 $114.51
7/31/202315,000,000 shares $1.87 billion +21.2%N/A5.3 $124.56
7/15/202312,380,000 shares $1.70 billion -0.2%N/A4.7 $137.32
A brutally honest economic warning for 2025 (see proof) (Ad)

New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....

Full details here.
6/30/202312,410,000 shares $1.59 billion -2.4%N/A5 $128.51
6/15/202312,710,000 shares $1.66 billion -10.9%N/A5.3 $130.98
5/31/202314,260,000 shares $1.67 billion -1.4%N/A6.3 $117.26
5/15/202314,460,000 shares $1.73 billion +13.6%N/A6.5 $119.61
4/30/202312,730,000 shares $1.54 billion +5.4%N/A5.4 $121.34
4/15/202312,080,000 shares $1.40 billion -2.7%N/A5.3 $115.70
3/31/202312,410,000 shares $1.44 billion -1.4%N/A5.1 $116.18
3/15/202312,580,000 shares $1.43 billion -2.7%N/A5.1 $113.72
2/28/202312,930,000 shares $1.44 billion -2.0%N/A4.9 $111.01
2/15/202313,190,000 shares $1.59 billion +18.7%N/A5 $120.17
1/31/202311,110,000 shares $1.19 billion -5.6%N/A4.4 $107.09
1/15/202311,770,000 shares $1.28 billion +1.0%N/A4.3 $108.47
12/30/202211,650,000 shares $1.32 billion -7.0%N/A4.2 $113.24
12/15/202212,530,000 shares $1.46 billion -3.4%N/A4.3 $116.24
11/30/202212,970,000 shares $1.51 billion +3.0%N/A4.6 $116.28
11/15/202212,590,000 shares $1.46 billion +5.8%N/A4.5 $116.31
10/31/202211,900,000 shares $1.44 billion -13.1%N/A4.3 $120.78
10/15/202213,690,000 shares $1.33 billion +4.5%N/A4.8 $97.41
9/30/202213,100,000 shares $1.06 billion -14.1%N/A4.8 $80.54
9/15/202215,250,000 shares $1.39 billion +6.3%N/A5.9 $90.98
8/31/202214,350,000 shares $1.18 billion +7.2%N/A5.2 $82.21
8/15/202213,390,000 shares $1.24 billion +10.2%N/A4 $92.30
7/31/202212,150,000 shares $997.27 million +3.5%N/A3.3 $82.08
7/15/202211,740,000 shares $929.10 million -3.0%N/A3.3 $79.14
6/30/202212,100,000 shares $901.81 million -6.9%N/A3.4 $74.53
6/15/202213,000,000 shares $929.63 million +293.9%14.8%3.6 $71.51
5/31/20223,300,000 shares $245.80 million -10.6%N/A3.7 $74.49
5/15/20223,690,000 shares $1.24 billion +10.5%N/A4.5 $334.74
4/30/20223,340,000 shares $1.36 billion -3.2%N/A4.2 $408.58
4/15/20223,450,000 shares $1.70 billion -2.8%3.6%4.4 $492.11
3/31/20223,550,000 shares $1.82 billion +4.1%3.7%4 $511.60
3/15/20223,410,000 shares $1.42 billion +0.6%3.6%4.1 $416.08
2/28/20223,390,000 shares $1.40 billion -1.5%3.5%3.8 $413.91
2/15/20223,440,000 shares $1.44 billion +7.2%3.6%3.8 $417.51
1/31/20223,210,000 shares $1.38 billion -3.3%3.4%3.9 $430.48
1/15/20223,320,000 shares $1.49 billion +8.9%N/A4.2 $447.34
12/31/20213,050,000 shares $1.64 billion -1.9%3.2%4.2 $536.95
12/15/20213,110,000 shares $1.68 billion -12.6%3.3%4.7 $541.29
11/30/20213,560,000 shares $2.00 billion -2.5%3.7%5.9 $562.59
11/15/20213,650,000 shares $2.34 billion +0.3%3.8%6.8 $641.95
10/29/20213,640,000 shares $2.27 billion +4.6%3.8%6.9 $623.21
10/15/20213,480,000 shares $1.89 billion +1.5%3.7%6.2 $544.47
9/30/20213,430,000 shares $1.88 billion -5.3%3.6%6 $546.86
9/15/20213,620,000 shares $2.00 billion -6.0%3.8%5.6 $551.67
8/31/20213,850,000 shares $2.04 billion -3.3%4.1%5.7 $529.42
8/13/20213,980,000 shares $1.96 billion -5.9%4.2%5.5 $491.41
7/30/20214,230,000 shares $2.18 billion -1.9%4.5%5.4 $515.51
7/15/20214,310,000 shares $1.90 billion +5.6%4.5%5.4 $441.42
6/30/20214,080,000 shares $1.74 billion +6.8%4.3%5.1 $427.00
6/15/20213,820,000 shares $1.55 billion +3.5%4.0%5 $405.10
A brutally honest economic warning for 2025 (see proof) (Ad)

New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....

Full details here.
5/28/20213,690,000 shares $1.36 billion -1.6%3.9%4.8 $369.39
5/14/20213,750,000 shares $1.21 billion +5.3%N/A4.7 $323.96
4/30/20213,560,000 shares $1.50 billion -2.2%N/A4.5 $421.70
4/15/20213,640,000 shares $1.42 billion +2.0%N/A4.8 $391.10
3/31/20213,570,000 shares $1.24 billion -3.0%N/A4.3 $347.20
3/15/20213,680,000 shares $1.32 billion -5.4%N/A4.2 $357.73
2/26/20213,890,000 shares $1.54 billion +2.9%N/A4.2 $395.47
2/12/20213,780,000 shares $1.55 billion +0.5%N/A3.9 $410.20
1/29/20213,760,000 shares $1.38 billion -0.3%N/A3.8 $366.89
1/15/20213,770,000 shares $1.33 billion +9.3%N/A3.2 $352.08
12/31/20203,450,000 shares $1.25 billion -1.2%N/A2.9 $362.77
12/15/20203,490,000 shares $1.23 billion +19.9%N/A3.1 $353.59
11/30/20202,910,000 shares $925.99 million +7.4%N/A2.7 $318.21
11/15/20202,710,000 shares $911.64 million -1.1%N/A2.6 $336.40
10/30/20202,740,000 shares $918.69 million -31.0%N/A2.9 $335.29
10/15/20203,970,000 shares $1.56 billion -4.1%N/A5.1 $394.01
9/30/20204,140,000 shares $1.71 billion +8.4%N/A5.2 $412.23
9/15/20203,820,000 shares $1.52 billion -1.0%N/A4.4 $397.97
8/31/20203,860,000 shares $1.64 billion +1.6%N/A4.1 $425.41
8/14/20203,800,000 shares $1.62 billion +3.3%N/A3.6 $425.16
7/31/20203,680,000 shares $1.60 billion -4.9%N/A2.4 $435.54
7/15/20203,870,000 shares $1.62 billion -1.5%4.3%2.3 $417.94
6/30/20203,930,000 shares $1.59 billion -10.7%4.3%2.2 $405.40
6/15/20204,400,000 shares $1.75 billion -7.8%4.9%2.4 $398.75
5/29/20204,770,000 shares $1.80 billion -16.8%5.3%2.5 $378.31
5/15/20205,730,000 shares $2.39 billion +17.4%6.3%3 $417.73
4/30/20204,880,000 shares $1.64 billion +7.3%5.4%2.7 $335.17
4/15/20204,550,000 shares $1.33 billion +4.4%5.0%3.5 $291.69
3/31/20204,360,000 shares $1.45 billion -1.9%4.8%3.6 $332.44

DXCM Short Interest - Frequently Asked Questions

What is DexCom's current short interest?

Short interest is the volume of DexCom shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 9,870,000 shares of DXCM short. 2.53% of DexCom's shares are currently sold short. Learn More on DexCom's current short interest.

What is a good short interest ratio for DexCom?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DXCM shares currently have a short interest ratio of 3.0. Learn More on DexCom's short interest ratio.

Which institutional investors are shorting DexCom?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DexCom: Wolverine Trading LLC, Squarepoint Ops LLC, Royal Bank of Canada, Maven Securities LTD, Millennium Management LLC, Hudson Bay Capital Management LP, Group One Trading LLC, Cubist Systematic Strategies LLC, Caption Management LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Lido Advisors LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, Hsbc Holdings PLC, HAP Trading LLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., JPMorgan Chase & Co., Simplex Trading LLC, Twin Tree Management LP, Garda Capital Partners LP, Wolverine Asset Management LLC, Intelligence Driven Advisers LLC, IMC Chicago LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for DexCom?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.53% of DexCom's floating shares are currently sold short.

Is DexCom's short interest increasing or decreasing?

DexCom saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 9,870,000 shares, an increase of 4.1% from the previous total of 9,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does DexCom's short interest compare to its competitors?

2.53% of DexCom's shares are currently sold short. Here is how the short interest of companies compare to DexCom: Becton, Dickinson and Company (1.03%), Edwards Lifesciences Co. (1.47%), IDEXX Laboratories, Inc. (3.40%), ResMed Inc. (5.99%), STERIS plc (1.06%), Insulet Co. (4.11%), Baxter International Inc. (4.12%), Hologic, Inc. (2.00%), Globus Medical, Inc. (2.36%), Masimo Co. (6.79%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

What does it mean to sell short DexCom stock?

Short selling DXCM is an investing strategy that aims to generate trading profit from DexCom as its price is falling. DXCM shares are trading up $1.52 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against DexCom?

A short squeeze for DexCom occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DXCM, which in turn drives the price of the stock up even further.

How often is DexCom's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DXCM, twice per month. The most recent reporting period available is February, 28 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:DXCM) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored